Login / Signup
Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis.
Lidia Sacchelli
A Patrizi
C Loi
F Bardazzi
Published in:
Clinical and experimental dermatology (2019)
Keyphrases
</>
combination therapy
ankylosing spondylitis
high intensity
coronary artery disease
early onset
atopic dermatitis
rheumatoid arthritis